AUSTIN, Texas (AP) — AUSTIN, Texas (AP) — Lumos Pharma, Inc. (LUMO) on Wednesday reported a loss of $7.3 million in its first quarter.
The Austin, Texas-based company said it had a loss of 89 cents per share.
The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.12 per share.
The biopharmaceutical company posted revenue of $691,000 in the period.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LUMO at https://www.zacks.com/ap/LUMO
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.